DK0723777T3 - Tablet indeholdende enteriske granuler - Google Patents

Tablet indeholdende enteriske granuler

Info

Publication number: DK0723777T3
Authority: DK; Denmark
Prior art keywords: granules; tablet; enteric; tableting; reduced
Prior art date: 1993-10-12

Application number

DK94929012T

Other languages

English (en)

Inventor

Tomohisa Matsushita

Mitsuo Hashimoto

Original Assignee

Mitsubishi Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-12

Filing date

1994-10-06

Publication date

2002-10-28

1994-10-06 Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp

2002-10-28 Application granted granted Critical

2002-10-28 Publication of DK0723777T3 publication Critical patent/DK0723777T3/da

Links

239000008187 granular material Substances 0.000 title abstract 7
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 abstract 1
229940024545 aluminum hydroxide Drugs 0.000 abstract 1
RJZNFXWQRHAVBP-UHFFFAOYSA-I aluminum;magnesium;pentahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Al+3] RJZNFXWQRHAVBP-UHFFFAOYSA-I 0.000 abstract 1
239000007931 coated granule Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 abstract 1
229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 abstract 1
239000000945 filler Substances 0.000 abstract 1
229960001545 hydrotalcite Drugs 0.000 abstract 1
229910001701 hydrotalcite Inorganic materials 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
235000017557 sodium bicarbonate Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK94929012T 1993-10-12 1994-10-06 Tablet indeholdende enteriske granuler DK0723777T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP25404993		1993-10-12
PCT/JP1994/001675 WO1995010264A1 (en)	1993-10-12	1994-10-06	Tablet containing enteric granules

Publications (1)

Publication Number	Publication Date
DK0723777T3 true DK0723777T3 (da)	2002-10-28

Family

ID=17259525

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94929012T DK0723777T3 (da)	1993-10-12	1994-10-06	Tablet indeholdende enteriske granuler

Country Status (12)

Country	Link
US (1)	US5798120A (da)
EP (1)	EP0723777B1 (da)
JP (1)	JP3710473B2 (da)
KR (1)	KR100353384B1 (da)
AT (1)	ATE219931T1 (da)
AU (1)	AU683092B2 (da)
CA (1)	CA2173506C (da)
DE (1)	DE69430921T2 (da)
DK (1)	DK0723777T3 (da)
ES (1)	ES2179079T3 (da)
PT (1)	PT723777E (da)
WO (1)	WO1995010264A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9402431D0 (sv) *	1994-07-08	1994-07-08	Astra Ab	New tablet formulation
WO1996001623A1 (en) *	1994-07-08	1996-01-25	Astra Aktiebolag	Multiple unit tableted dosage form i
SE9500422D0 (sv) *	1995-02-06	1995-02-06	Astra Ab	New oral pharmaceutical dosage forms
US6699885B2 (en) *	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6645988B2 (en) *	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients I
SE512835C2 (sv) *	1996-01-08	2000-05-22	Astrazeneca Ab	Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600072D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients II
SE9600070D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
WO1998023272A1 (en) *	1996-11-27	1998-06-04	The Procter & Gamble Company	Compositions and methods for the treatment of gastrointestinal disorders
JP3870470B2 (ja) *	1997-02-07	2007-01-17	大正製薬株式会社	マルチプルユニットタイプ徐放性錠剤
US6096340A (en)	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6174548B1 (en)	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6558700B1 (en)	1998-04-17	2003-05-06	Taisho Pharmaceutical Co., Ltd.	Multiple-unit sustained release tablets
WO1999059544A2 (en)	1998-05-18	1999-11-25	Takeda Chemical Industries, Ltd.	Orally disintegrable tablets
ATE481090T1 (de) *	1998-07-28	2010-10-15	Takeda Pharmaceutical	Leicht zerfallende feste zubereitung
US6733778B1 (en)	1999-08-27	2004-05-11	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6544556B1 (en)	2000-09-11	2003-04-08	Andrx Corporation	Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
CA2517005A1 (en) *	2003-02-20	2004-09-02	Santarus, Inc.	A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
KR20120102571A (ko) *	2003-02-24	2012-09-18	미쓰비시 타나베 파마 코퍼레이션	테나토프라졸의 거울상 이성질체 및 치료를 위한 그 용도
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7670624B2 (en) *	2004-01-29	2010-03-02	Astella Pharma Inc.	Gastrointestinal-specific multiple drug release system
US8815916B2 (en)	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN101460154B (zh)	2006-04-04	2015-07-01	Kg艾克维泽生公司	包含抗血小板剂和抑酸剂的口服剂型
WO2007138606A2 (en) *	2006-06-01	2007-12-06	Dexcel Pharma Technologies Ltd.	Multiple unit pharmaceutical formulation
JP5041774B2 (ja) *	2006-09-22	2012-10-03	日本ケミファ株式会社	メサラジンを有効成分として含有する徐放性錠剤
JP4329947B1 (ja) *	2009-01-20	2009-09-09	ライオン株式会社	内服用錠剤
CN102198131A (zh) *	2010-03-24	2011-09-28	济南瑞安药业发展有限公司	一种含有奥美拉唑的新的复方制剂
SG190717A1 (en) *	2010-12-03	2013-07-31	Takeda Pharmaceutical	Orally disintegrating tablet
WO2016174664A1 (en)	2015-04-29	2016-11-03	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB971486A (en) *	1960-04-01	1964-09-30	Rech S Pharma Et Scient	Therapeutic compositions comprising aspirin and polysiloxanes
CA1259924A (en) *	1985-03-25	1989-09-26	Wallace E. Becker	Pharmaceutical tableting method
US4874614A (en) *	1985-03-25	1989-10-17	Abbott Laboratories	Pharmaceutical tableting method
CA1327010C (en) *	1986-02-13	1994-02-15	Tadashi Makino	Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
JPH0780754B2 (ja) *	1986-08-06	1995-08-30	エーザイ株式会社	多顆粒型持続性錠剤
JP2514078B2 (ja) *	1988-08-22	1996-07-10	エスエス製薬株式会社	圧縮成型製剤
JP2781442B2 (ja) *	1990-02-19	1998-07-30	旭化成工業株式会社	顆粒含有錠剤
JP2856485B2 (ja) *	1990-03-07	1999-02-10	旭化成工業株式会社	顆粒含有錠

1994
- 1994-10-06 WO PCT/JP1994/001675 patent/WO1995010264A1/ja not_active Ceased
- 1994-10-06 ES ES94929012T patent/ES2179079T3/es not_active Expired - Lifetime
- 1994-10-06 AT AT94929012T patent/ATE219931T1/de active
- 1994-10-06 CA CA002173506A patent/CA2173506C/en not_active Expired - Lifetime
- 1994-10-06 PT PT94929012T patent/PT723777E/pt unknown
- 1994-10-06 KR KR1019960701804A patent/KR100353384B1/ko not_active Expired - Lifetime
- 1994-10-06 US US08/624,510 patent/US5798120A/en not_active Expired - Lifetime
- 1994-10-06 AU AU78222/94A patent/AU683092B2/en not_active Expired
- 1994-10-06 DE DE69430921T patent/DE69430921T2/de not_active Expired - Lifetime
- 1994-10-06 EP EP94929012A patent/EP0723777B1/en not_active Expired - Lifetime
- 1994-10-06 DK DK94929012T patent/DK0723777T3/da active
- 1994-10-06 JP JP51158095A patent/JP3710473B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU7822294A (en)	1995-05-04
AU683092B2 (en)	1997-10-30
ES2179079T3 (es)	2003-01-16
ATE219931T1 (de)	2002-07-15
PT723777E (pt)	2002-11-29
DE69430921D1 (de)	2002-08-08
KR100353384B1 (ko)	2002-12-28
DE69430921T2 (de)	2003-02-13
JP3710473B2 (ja)	2005-10-26
CA2173506A1 (en)	1995-04-20
WO1995010264A1 (en)	1995-04-20
EP0723777A1 (en)	1996-07-31
US5798120A (en)	1998-08-25
KR960704531A (ko)	1996-10-09
CA2173506C (en)	2006-05-09
EP0723777A4 (en)	1997-06-25
EP0723777B1 (en)	2002-07-03

Publication	Publication Date	Title
DK0723777T3 (da)	2002-10-28	Tablet indeholdende enteriske granuler
US3074852A (en)	1963-01-22	Pharmaceuticals with delayed release
KR910004180A (ko)	1991-03-28	저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정
ZA856597B (en)	1986-04-30	Pellet formulation
IE890929L (en)	1989-09-30	Pharmaceutical compositions having good stability
KR890016968A (ko)	1989-12-14	약제 흡착물
JPH0155244B2 (da)	1989-11-22
EP0103387A3 (en)	1984-12-12	Long-acting matrix tablet formulations
IE821861L (en)	1983-02-05	Pharmaceutical compositions
NO865195D0 (no)	1986-12-19	Fremgangsmaate for fremstilling av et retardpreparat av ibuprofen.
HK80492A (en)	1992-10-30	Pharmaceutical compositions with analgesic properties and the preparation and use thereof
CA1157376A (en)	1983-11-22	Pharmaceutical compositions containing paracetamol
KR927002213A (ko)	1992-09-03	유효성분의 과립을 매끈하게 하는 방법
ATE238784T1 (de)	2003-05-15	Granulat mit hohem gehalt an l-carnitine oder einem alkanoyl l-carnitine, insbesondere für die herstellung von direktverpressten tabletten
JPS5533425A (en)	1980-03-08	Production of gradually releasing preparation
US2889248A (en)	1959-06-02	Therapeutic composition containing aluminum proteinate
RU97105420A (ru)	1999-05-10	Твердая лекарственная форма на основе сульфаметоксазола и триметоприма
JPS52138583A (en)	1977-11-18	Preparation of vinyl chloride polymers
EP0106028A3 (en)	1985-10-30	Novel diuretic/antihypertensive compositions and methods of preparation
RU96123569A (ru)	1999-01-27	Лекарственный препарат
JP2001187738A (ja)	2001-07-10	アスピリン含有製剤製品
KR970014764A (ko)	1997-04-28	케토프로펜을 함유하는 제약학적 혼합물 제제
TH13475A (th)	1993-12-15	สูตรผสมทางเภสัชกรรม
CN101351194A (zh)	2009-01-21	包装
JPS5282993A (en)	1977-07-11	Preparation of block copolymers